Multi-Valent mRNA Vaccines: Strategies for Effective Design & Potency Assessment

Time: 11:00 am
day: Conference Day One


  • Investigate the complexities of developing multi-valent mRNA vaccines to combat various infectious diseases
  • What are quantitative potency assays for multi-valent vaccines and their challenges posed by variant-specific antibodies
  • What are the potential engineering approaches to simplify potency assessments for multi-valent mRNA vaccines